Abstract
The eye is a major target for stem cell transplantation therapy because of the preponderance of eye illness, providing both good surgical accessibility and the ability to visually monitor changes following transplantation. Risks of extension and tumor development after intraocular stem cell transplantation can be controlled using laser ablation and, in severe situations, evisceration or enucleation. Additionally, cutting-edge techniques exist for evaluating the clinical significance of eye tissue transplant results.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
